KLF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.38720000003789E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.399220E-03 |
Normal-vs-Stage2 |
3.621300E-03 |
Normal-vs-Stage3 |
8.20799994638577E-09 |
Normal-vs-Stage4 |
1.83729997882409E-09 |
Stage1-vs-Stage2 |
4.220200E-01 |
Stage1-vs-Stage3 |
1.67419999974605E-07 |
Stage1-vs-Stage4 |
4.8008999997684E-08 |
Stage2-vs-Stage3 |
8.971800E-02 |
Stage2-vs-Stage4 |
4.099700E-02 |
Stage3-vs-Stage4 |
4.674600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.77019999997508E-06 |
Normal-vs-AfricanAmerican |
3.92390000003573E-06 |
Normal-vs-Asian |
8.578600E-01 |
Caucasian-vs-AfricanAmerican |
3.381600E-01 |
Caucasian-vs-Asian |
1.929940E-02 |
AfricanAmerican-vs-Asian |
7.503400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.12189999995827E-06 |
Normal-vs-Female |
3.54710000000091E-05 |
Male-vs-Female |
6.211200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.043800E-03 |
Normal-vs-Age(41-60Yrs) |
8.0094000000086E-05 |
Normal-vs-Age(61-80Yrs) |
4.41960000041597E-07 |
Normal-vs-Age(81-100Yrs) |
3.2976999999601E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.255200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.442200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.627990E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.539650E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.330400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.431840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.270600E-01 |
Normal-vs-Grade 2 |
3.376100E-03 |
Normal-vs-Grade 3 |
2.40149999886086E-08 |
Normal-vs-Grade 4 |
8.51720027839065E-10 |
Grade 1-vs-Grade 2 |
3.377000E-01 |
Grade 1-vs-Grade 3 |
2.395400E-04 |
Grade 1-vs-Grade 4 |
4.11200000000056E-05 |
Grade 2-vs-Grade 3 |
1.67780000004392E-07 |
Grade 2-vs-Grade 4 |
1.49519999714798E-08 |
Grade 3-vs-Grade 4 |
6.385900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.575700E-03 |
Normal-vs-ccB subtype |
6.41339999996049E-07 |
ccA subtype-vs-ccB subtype |
9.77309999999898E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.60046999999608E-05 |
Normal-vs-N1 |
9.140500E-03 |
N0-vs-N1 |
5.658400E-01 |
|
|